Harvard Bioscience Announces First Quarter 2026 Financial Results

Go back to Harvard Bioscience Announces First Quarter 2026 Financial Results
Harvard Bioscience, Inc. (NASDAQ: HBIO) Delayed: 7.96 -0.06 (0.75%)
Previous Close $8.02    52 Week High $3.90 
Open $8.02    52 Week Low $2.25 
Day High $8.05    P/E N/A 
Day Low $7.92    EPS $-0.03 
Volume 5,009